{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-004245","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.992997+00:00","generated_at":"2026-05-16T06:21:47.944571+00:00","sec_items":["3.02","8.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Daré Bioscience closes initial tranche of Reg A offering at $5/unit; issues 5,090 units","bullets":["Initial closing on Jan 27, 2026: issued 5,090 Units (each 1 share Series A Preferred + 2 warrants) for $25,450 gross proceeds.","Series A Preferred convertible at $2.50/share, no dividends, liquidation preference $5/share, senior to common stock.","Investor warrants exercisable at $4.00/share for 36 months; Agent warrants at $6.25/unit, subject to 180-day lock-up.","Company can call preferred after 3 years at lesser of stated value + 8% annual or 200% of stated value.","Forced conversion triggers: change of control, stock price ≥$4.50 for 10 of 30 days, or firm IPO ≥$15M at ≥$4.50."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-004245","json":"https://secwatch.observer/filing/0001493152-26-004245.json","markdown":"https://secwatch.observer/filing/0001493152-26-004245.md","text":"https://secwatch.observer/filing/0001493152-26-004245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:21:47.944571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"236467a7974ffbcaa76a0f4b0899d4375645b9a4","claim":"Dare Bioscience, Inc.: Filed Certificate of Designation designating 4,999,620 shares as Series A Convertible Preferred Stock, establishing powers, preferences, and rights (effective 2026-01-23).","evidence_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0002045458-26-000015","ticker":null,"company_name":"Stonepeak-Plus Infrastructure Fund LP","filed_at":"2026-05-05T23:59:59+00:00","headline":"Stonepeak-Plus Infrastructure Fund sells $65M in units, declares March distributions","event_type":"other_material","sec_items":["1.01","3.02","8.01","5.03","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0002045458-26-000015","json":"https://secwatch.observer/filing/0002045458-26-000015.json","markdown":"https://secwatch.observer/filing/0002045458-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/0002045458-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/sp-20260429.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"On May 4, 2026, Stonepeak-Plus Infrastructure Fund Associates LP, the general partner of the Fund (the “General Partner”), entered into the Third Amended and Restated Limited Partnership Agreement of the Fund (the “Amended Partnership Agreement”), to (i) authorize the General Partner to cause the Fund to issue Units designated as Class Z - Series D-2 Units, Class Z - Series I-2 Units and Class Z - Series S-2 Units, and cancel Class D-2 Units, Class I-2 Units and Class S-2 Units, each of which have not been issued, and (ii) make certain related changes and incorporate other administrative updates.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/0002045458-26-000015-index.htm"}},{"accession":"0001213900-26-061039","ticker":"AIDX","company_name":"20/20 Biolabs, Inc.","filed_at":"2026-05-26T20:28:45+00:00","headline":"20/20 Biolabs reduces stockholder meeting quorum from majority to one-third","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061039","json":"https://secwatch.observer/filing/0001213900-26-061039.json","markdown":"https://secwatch.observer/filing/0001213900-26-061039.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/0001213900-26-061039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/ea0292180-8k_2020bio.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"On May 19, 2026, the Board of Directors of 20/20 Biolabs, Inc. (the “ Company ”) adopted Amendment No. 1 to the Company’s Amended and Restated Bylaws (the “ Amendment ”), pursuant to which Section 2.5 of the Company’s Amended and Restated Bylaws was amended to reduce the quorum required for a meeting of stockholders from a majority of the shares outstanding to one-third of the shares outstanding.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026061039/0001213900-26-061039-index.htm"}},{"accession":"0000072162-26-000034","ticker":"NL","company_name":"NL INDUSTRIES INC","filed_at":"2026-05-26T20:16:09+00:00","headline":"NL Industries reincorporates in Delaware as NLI Holdings, effective May 26, 2026","event_type":"other_material","sec_items":["1.01","2.01","2.03","3.03","5.02","5.03","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000072162-26-000034","json":"https://secwatch.observer/filing/0000072162-26-000034.json","markdown":"https://secwatch.observer/filing/0000072162-26-000034.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/0000072162-26-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/nl-20260519x8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"At the Effective Time, the affairs of the Company ceased to be governed by the NJBCA and the Predecessor Corporation’s certificate of incorporation and bylaws, and instead became governed by the DGCL, the Delaware Certificate and the Bylaws.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/72162/000007216226000034/0000072162-26-000034-index.htm"}},{"accession":"0001193125-26-214945","ticker":"MAN","company_name":"ManpowerGroup Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"ManpowerGroup declares $0.72 dividend; shareholders approve equity plan amendment and director removal without cause","event_type":"other_material","sec_items":["5.02","5.03","5.07","8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214945","json":"https://secwatch.observer/filing/0001193125-26-214945.json","markdown":"https://secwatch.observer/filing/0001193125-26-214945.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/man-20260508.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm"}},{"accession":"0000001961-26-000006","ticker":null,"company_name":"WORLDS INC","filed_at":"2026-06-01T18:59:55+00:00","headline":"Worlds Inc. changes name to Gemaxel Inc., effective March 26, 2026","event_type":"other_material","sec_items":["5.03","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000001961-26-000006","json":"https://secwatch.observer/filing/0000001961-26-000006.json","markdown":"https://secwatch.observer/filing/0000001961-26-000006.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1961/000000196126000006/0000001961-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1961/000000196126000006/wddd8k052826.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"On March 26, 2026 the Company amended ARTICLE FIRST of its Certificate of Incorporation and changed its name to Gemaxel Inc. from Worlds Inc.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1961/000000196126000006/0000001961-26-000006-index.htm"}},{"accession":"0001493152-26-026548","ticker":"BTCS","company_name":"BTCS Inc.","filed_at":"2026-06-01T13:29:19+00:00","headline":"BTCS reduces stockholder quorum requirement from majority to 33.3%","event_type":"other_material","sec_items":["5.03","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026548","json":"https://secwatch.observer/filing/0001493152-26-026548.json","markdown":"https://secwatch.observer/filing/0001493152-26-026548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1436229/000149315226026548/0001493152-26-026548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1436229/000149315226026548/form8-k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"On May 29, 2026, the board of directors of BTCS Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws (the “Bylaws”) and adopted an amendment to the quorum requirement contained in Article II, Section 2.9 of the Bylaws (the “Amendment”) to provide that the holders of thirty-three and one third percent (33.3%) of the voting power of the Company entitled to vote at a meeting of stockholders, present in person or represented by proxy, shall constitute a quorum for the transaction of business.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1436229/000149315226026548/0001493152-26-026548-index.htm"}},{"accession":"0001213900-26-062807","ticker":"LRHC","company_name":"La Rosa Holdings Corp.","filed_at":"2026-05-29T20:05:32+00:00","headline":"La Rosa Holdings corrects Series D Preferred Stock share count from 250 to 500","event_type":"other_material","sec_items":["5.03","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062807","json":"https://secwatch.observer/filing/0001213900-26-062807.json","markdown":"https://secwatch.observer/filing/0001213900-26-062807.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026062807/0001213900-26-062807-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026062807/ea0292539-8ka1_larosa.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Nevada Secretary of State a Certificate of Correction (the “Certificate of Correction”) to the Certificate of Designation of Series D Preferred Stock to correct an inadvertent error in the authorized number of shares of Series D Convertible Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”), that the Company is authorized to issue by modifying Section 1 of the Certificate of Designation of Series D Preferred Stock to correctly state that the number of authorized shares of Series D Preferred Stock is 500 shares instead of 250 shares.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026062807/0001213900-26-062807-index.htm"}},{"accession":"0000356171-26-000079","ticker":"TCBK","company_name":"TRICO BANCSHARES /","filed_at":"2026-05-28T01:34:00+00:00","headline":"TriCo Bancshares annual meeting: cumulative voting eliminated, directors elected","event_type":"other_material","sec_items":["5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000356171-26-000079","json":"https://secwatch.observer/filing/0000356171-26-000079.json","markdown":"https://secwatch.observer/filing/0000356171-26-000079.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/0000356171-26-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/tcbk-20260521.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 23, 2026, in anticipation of the initial closing of the Offering (as defined below), Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) filed a Certificate of Designation of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, which became effective upon filing.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm","comparable_excerpt":"the Board implemented the Amendment by adopting and approving amended and restated bylaws","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/356171/000035617126000079/0000356171-26-000079-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}